← All drugs
Drug

Tobramycin And Dexamethasone

182 flagged reaction(s) · 4,148 total co-reports · max PRR 50.1
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Intraocular Pressure Increased 100 50.1 51.7 signal
2 Retinal Detachment 48 33.5 34.0 signal
3 Eye Infection 49 28.0 28.4 signal
4 Eye Pain 241 28.0 30.1 signal
5 Photophobia 81 27.8 28.5 signal
6 Eye Inflammation 38 25.8 26.1 signal
7 Conjunctivitis 73 25.5 26.0 signal
8 Uveitis 53 25.1 25.5 signal
9 Ocular Hyperaemia 167 22.9 24.1 signal
10 Eye Discharge 34 21.3 21.5 signal
11 Ocular Discomfort 36 21.2 21.5 signal
12 Eye Irritation 168 19.3 20.3 signal
13 Lacrimation Increased 85 18.2 18.7 signal
14 Glaucoma 51 16.9 17.2 signal
15 Eye Swelling 89 15.4 15.8 signal
16 Visual Acuity Reduced 76 14.5 14.8 signal
17 Osteopenia 34 14.3 14.4 signal
18 Economic Problem 32 13.3 13.4 signal
19 Eyelid Oedema 24 13.1 13.2 signal
20 Eyelid Ptosis 20 12.6 12.6 signal
21 Eye Pruritus 64 12.4 12.6 signal
22 Eye Disorder 57 11.1 11.3 signal
23 Ear Discomfort 17 10.6 10.7 signal
24 Blindness Unilateral 23 10.4 10.5 signal
25 Vitreous Floaters 15 9.8 9.9 signal
26 Cataract 91 9.8 10.1 signal
27 Hyperlipidaemia 18 9.6 9.6 signal
28 Dry Eye 72 9.5 9.7 signal
29 Toxic Skin Eruption 15 9.5 9.5 signal
30 Intervertebral Disc Degeneration 13 8.9 9.0 signal
31 Madarosis 16 8.7 8.8 signal
32 Vision Blurred 180 8.4 8.9 signal
33 Impaired Quality Of Life 18 8.0 8.0 signal
34 Mitral Valve Incompetence 14 7.9 7.9 signal
35 Ejection Fraction Decreased 19 7.8 7.8 signal
36 Seasonal Allergy 17 7.7 7.7 signal
37 Eye Haemorrhage 16 7.6 7.7 signal
38 Tooth Abscess 12 7.5 7.5 signal
39 Arteriosclerosis 11 7.5 7.5 signal
40 Product Use Complaint 18 7.4 7.5 signal
41 Tinnitus 53 7.4 7.5 signal
42 End Stage Renal Disease 21 7.3 7.3 signal
43 Cyst 14 7.2 7.2 signal
44 Chronic Kidney Disease 80 6.7 6.8 signal
45 Tendonitis 16 6.6 6.6 signal
46 Visual Impairment 119 6.2 6.4 signal
47 Supraventricular Tachycardia 9 6.0 6.0 signal
48 Post Procedural Complication 18 6.0 6.0 signal
49 Blindness 38 6.0 6.0 signal
50 Haemorrhoids 18 5.9 5.9 signal
51 Temperature Intolerance 9 5.6 5.6 signal
52 Presyncope 21 5.5 5.6 signal
53 Ventricular Extrasystoles 9 5.5 5.5 signal
54 Disability 17 5.5 5.5 signal
55 Diplopia 22 5.4 5.4 signal
56 Inflammation 43 5.4 5.4 signal
57 Anhedonia 22 5.3 5.3 signal
58 Bursitis 10 5.3 5.3 signal
59 Staphylococcal Infection 27 5.2 5.2 signal
60 Secretion Discharge 10 5.2 5.2 signal
61 Sleep Apnoea Syndrome 15 5.0 5.0 signal
62 Rash Maculo-papular 17 4.9 4.9 signal
63 Immune System Disorder 10 4.9 4.9 signal
64 Macular Degeneration 9 4.8 4.8 signal
65 Bacterial Infection 14 4.8 4.8 signal
66 Product Packaging Quantity Issue 8 4.7 4.7 signal
67 Photosensitivity Reaction 12 4.7 4.7 signal
68 Hypomagnesaemia 10 4.6 4.6 signal
69 Vitamin D Deficiency 7 4.6 4.6 signal
70 Ear Infection 19 4.6 4.6 signal
71 Pelvic Pain 13 4.6 4.6 signal
72 Ligament Sprain 7 4.5 4.5 signal
73 Dermatitis Contact 8 4.5 4.5 signal
74 Impaired Driving Ability 8 4.5 4.5 signal
75 Emphysema 7 4.4 4.4 signal
76 Osteomyelitis 12 4.2 4.2 signal
77 Toxic Epidermal Necrolysis 10 4.2 4.2 signal
78 Coronary Artery Disease 20 4.2 4.2 signal
79 Product Administration Error 13 4.2 4.2 signal
80 Face Oedema 11 4.1 4.2 signal
81 Carpal Tunnel Syndrome 9 4.1 4.1 signal
82 Muscle Atrophy 8 4.1 4.1 signal
83 Mydriasis 8 4.0 4.0 signal
84 Rotator Cuff Syndrome 8 4.0 4.0 signal
85 Ear Pain 12 3.9 4.0 signal
86 Hiatus Hernia 8 3.9 3.9 signal
87 Gastrooesophageal Reflux Disease 49 3.9 3.9 signal
88 Injury 43 3.9 3.9 signal
89 Cardiomyopathy 9 3.9 3.9 signal
90 Toothache 11 3.9 3.9 signal
91 Sinus Disorder 12 3.9 3.9 signal
92 Hypoaesthesia Oral 9 3.8 3.8 signal
93 Intervertebral Disc Protrusion 13 3.8 3.8 signal
94 Sinus Congestion 8 3.8 3.8 signal
95 Pleural Effusion 35 3.7 3.7 signal
96 Deafness 15 3.7 3.7 signal
97 Oral Herpes 11 3.6 3.6 signal
98 Breast Pain 6 3.6 3.6 signal
99 Body Height Decreased 6 3.5 3.5 signal
100 Infusion Site Pain 7 3.5 3.5 signal
101 Dental Caries 6 3.5 3.5 signal
102 Increased Tendency To Bruise 5 3.5 3.5 signal
103 Insurance Issue 8 3.4 3.4 signal
104 Erythema Multiforme 5 3.4 3.4 signal
105 Incorrect Route Of Product Administration 9 3.4 3.4 signal
106 Deformity 5 3.4 3.4 signal
107 Scab 6 3.4 3.4 signal
108 Sputum Discoloured 5 3.4 3.4 signal
109 Drug Dispensing Error 8 3.3 3.3 signal
110 Eosinophilia 9 3.3 3.3 signal
111 Post Procedural Haemorrhage 6 3.3 3.3 signal
112 Discomfort 31 3.3 3.3 signal
113 Anaphylactic Shock 13 3.2 3.2 signal
114 Hypersensitivity 94 3.2 3.3 signal
115 Body Temperature Decreased 5 3.2 3.2 signal
116 Skin Reaction 7 3.2 3.2 signal
117 Sleep Disorder Due To A General Medical Condition 8 3.2 3.2 signal
118 Restless Legs Syndrome 9 3.2 3.2 signal
119 Dialysis 7 3.1 3.1 signal
120 Swelling Face 32 3.1 3.2 signal
121 Dermatitis 10 3.1 3.1 signal
122 Dermatitis Atopic 24 3.1 3.1 signal
123 Renal Injury 14 3.0 3.0 signal
124 Musculoskeletal Discomfort 8 3.0 3.0 signal
125 Rectal Haemorrhage 20 3.0 3.0 signal
126 Stevens-johnson Syndrome 10 2.9 2.9 signal
127 Basal Cell Carcinoma 7 2.9 2.9 signal
128 Osteonecrosis Of Jaw 11 2.8 2.8 signal
129 Coronary Artery Occlusion 6 2.8 2.8 signal
130 Blood Thyroid Stimulating Hormone Increased 4 2.8 2.8 no signal
131 Muscle Tightness 7 2.8 2.8 signal
132 Drug Reaction With Eosinophilia And Systemic Symptoms 11 2.7 2.8 signal
133 Emotional Distress 52 2.7 2.8 signal
134 Pemphigus 5 2.6 2.6 no signal
135 Multi-organ Failure 7 2.5 2.6 signal
136 Activities Of Daily Living Impaired 8 2.5 2.5 signal
137 Ovarian Cyst 4 2.5 2.5 no signal
138 Bone Loss 6 2.5 2.5 signal
139 Blood Triglycerides Increased 7 2.5 2.5 signal
140 Gallbladder Disorder 7 2.5 2.5 signal
141 Product Prescribing Error 9 2.4 2.4 signal
142 Dysgeusia 28 2.4 2.4 signal
143 Rebound Effect 4 2.3 2.3 no signal
144 Hepatocellular Injury 5 2.2 2.2 no signal
145 Hypoacusis 15 2.2 2.2 signal
146 Metastases To Lung 4 2.2 2.2 no signal
147 Nightmare 12 2.2 2.2 signal
148 Eczema 17 2.2 2.2 signal
149 Extrapyramidal Disorder 8 2.0 2.0 no signal
150 Tardive Dyskinesia 9 2.0 2.0 no signal
151 Bone Density Decreased 10 2.0 2.0 signal
152 Product Quality Issue 42 2.0 2.0 no signal
153 Affect Lability 3 2.0 2.0 no signal
154 Decreased Immune Responsiveness 3 2.0 2.0 no signal
155 Metastases To Bone 5 2.0 2.0 no signal
156 Inability To Afford Medication 3 1.9 1.9 no signal
157 Incorrect Route Of Drug Administration 11 1.9 1.9 no signal
158 Product Dose Omission In Error 8 1.9 1.9 no signal
159 Incorrect Product Administration Duration 6 1.9 1.9 no signal
160 Product Odour Abnormal 3 1.8 1.8 no signal
161 Skeletal Injury 3 1.8 1.8 no signal
162 Diabetes Mellitus Inadequate Control 5 1.8 1.8 no signal
163 Glycosylated Haemoglobin Increased 7 1.8 1.8 no signal
164 Plasma Cell Myeloma 10 1.6 1.6 no signal
165 Diabetic Ketoacidosis 6 1.6 1.6 no signal
166 Osteonecrosis 8 1.5 1.5 no signal
167 Multiple Fractures 4 1.5 1.5 no signal
168 Expired Product Administered 8 1.5 1.5 no signal
169 Product Dispensing Error 5 1.5 1.5 no signal
170 Psoriatic Arthropathy 9 1.4 1.4 no signal
171 Product Taste Abnormal 3 1.4 1.4 no signal
172 Hair Texture Abnormal 3 1.4 1.4 no signal
173 Device Failure 3 1.3 1.3 no signal
174 Product Storage Error 16 1.2 1.2 no signal
175 Application Site Pain 4 1.2 1.2 no signal
176 Skin Irritation 8 1.1 1.1 no signal
177 Synovitis 3 1.1 1.1 no signal
178 Product Administered At Inappropriate Site 3 1.1 1.1 no signal
179 Device Dislocation 6 0.9 0.9 no signal
180 Accidental Exposure To Product 13 0.8 0.8 no signal
181 Injection Site Swelling 9 0.8 0.8 no signal
182 Pharmaceutical Product Complaint 3 0.7 0.7 no signal